This site uses cookies. To learn more, please visit our Privacy Policy. By continuing to surf on our website, you consent to our use of cookies Close [X]
Blood Plasma Derivatives Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others); Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrands Disease (vWD), Other Application); End User (Hospitals, Clinics, Other End Users) and Geography
Product derived from blood plasma on fractionation are called as plasma derivatives. Plasma derivatives are widely used to treat different diseases. Blood plasma helps to maintain pH level of body fluid. It is one of the important blood component in which WBC's and platelets are suspended. It also helps in transporting nutrients throughout the body. Blood plasma contains more than 100 different components such as fibrinogen, albumin, immunoglobulins, clotting factors and protease inhibitors. There are variety of plasma derivatives available in market include albumin, factor VIII & IX, anti-inhibitor coagulation complex (AICC), immunoglobulins, including Rh immune globulin, alpha 1-proteinase inhibitor concentrate, and anti-thrombin III concentrate.
MARKET DYNAMICS
The Blood Plasma Derivatives market is anticipated to grow in the forecast period owing to driving factors such as rising prevalence of diseases such as immunodeficiency diseases, hemophilia, etc., rising awareness towards blood & blood component donation, rising geriatric population, and adoption of blood plasma derivatives products.
MARKET SCOPE
The "Global Blood Plasma Derivatives Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Blood Plasma Derivatives market with detailed market segmentation by type, application, end user, and geography. The global Blood Plasma Derivatives market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Blood Plasma Derivatives market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Blood Plasma Derivatives market is segmented on the basis of type, application, and end user. Based on type, the market is segmented into Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and others. Based on application, the market is segmented into Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrands Disease (vWD), and other application. Based on end user, the market is segmented into hospitals, clinics, and other end users.
Get more information on this report :
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Blood Plasma Derivatives market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Blood Plasma Derivatives market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Blood Plasma Derivatives market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Blood Plasma Derivatives market in these regions.
Get more information on this report :
MARKET PLAYERS
The reports cover key developments in the Blood Plasma Derivatives market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Blood Plasma Derivatives market are anticipated to lucrative growth opportunities in the future with the rising demand for Blood Plasma Derivatives market in the global market. Below mentioned is the list of few companies engaged in the Blood Plasma Derivatives market.
The report also includes the profiles of key Blood Plasma Derivatives market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Grifols, S.A.
SK Plasma Co., Ltd.
Fusion Health Care Pvt. Ltd.
Biotest AG
Green Cross Corporation
Baxter International Inc.
LFB S.A.
Octapharma AG
CSL Limited
Shire Plc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION 1.1. SCOPE OF THE STUDY 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 1.3. MARKET SEGMENTATION 1.3.1 Blood Plasma Derivatives Market - By Type 1.3.2 Blood Plasma Derivatives Market - By Application 1.3.3 Blood Plasma Derivatives Market - By End User 1.3.4 Blood Plasma Derivatives Market - By Region 1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BLOOD PLASMA DERIVATIVES MARKET LANDSCAPE 4.1. OVERVIEW 4.2. PEST ANALYSIS 4.2.1 North America - Pest Analysis 4.2.2 Europe - Pest Analysis 4.2.3 Asia-Pacific - Pest Analysis 4.2.4 Middle East and Africa - Pest Analysis 4.2.5 South and Central America - Pest Analysis 4.3. EXPERT OPINIONS
6. BLOOD PLASMA DERIVATIVES MARKET - GLOBAL MARKET ANALYSIS 6.1. BLOOD PLASMA DERIVATIVES - GLOBAL MARKET OVERVIEW 6.2. BLOOD PLASMA DERIVATIVES - GLOBAL MARKET AND FORECAST TO 2027 6.3. MARKET POSITIONING/MARKET SHARE
7. BLOOD PLASMA DERIVATIVES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE 7.1. OVERVIEW 7.2. TYPE MARKET FORECASTS AND ANALYSIS 7.3. ALBUMIN 7.3.1. Overview 7.3.2. Albumin Market Forecast and Analysis 7.4. FACTOR VIII 7.4.1. Overview 7.4.2. Factor VIII Market Forecast and Analysis 7.5. FACTOR IX 7.5.1. Overview 7.5.2. Factor IX Market Forecast and Analysis 7.6. IMMUNOGLOBULIN 7.6.1. Overview 7.6.2. Immunoglobulin Market Forecast and Analysis 7.7. HYPERIMMUNE GLOBULIN 7.7.1. Overview 7.7.2. Hyperimmune Globulin Market Forecast and Analysis 7.8. OTHERS 7.8.1. Overview 7.8.2. Others Market Forecast and Analysis 8. BLOOD PLASMA DERIVATIVES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION 8.1. OVERVIEW 8.2. APPLICATION MARKET FORECASTS AND ANALYSIS 8.3. HEMOPHILIA 8.3.1. Overview 8.3.2. Hemophilia Market Forecast and Analysis 8.4. HYPOGAMMAGLOBULINEMIA 8.4.1. Overview 8.4.2. Hypogammaglobulinemia Market Forecast and Analysis 8.5. IMMUNODEFICIENCY DISEASES 8.5.1. Overview 8.5.2. Immunodeficiency Diseases Market Forecast and Analysis 8.6. VON WILLEBRANDS DISEASE (VWD) 8.6.1. Overview 8.6.2. von Willebrands Disease (vWD) Market Forecast and Analysis 8.7. OTHER APPLICATION 8.7.1. Overview 8.7.2. Other Application Market Forecast and Analysis 9. BLOOD PLASMA DERIVATIVES MARKET - REVENUE AND FORECASTS TO 2027 - END USER 9.1. OVERVIEW 9.2. END USER MARKET FORECASTS AND ANALYSIS 9.3. HOSPITALS 9.3.1. Overview 9.3.2. Hospitals Market Forecast and Analysis 9.4. CLINICS 9.4.1. Overview 9.4.2. Clinics Market Forecast and Analysis 9.5. OTHER END USERS 9.5.1. Overview 9.5.2. Other End Users Market Forecast and Analysis 10. BLOOD PLASMA DERIVATIVES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS 10.1. NORTH AMERICA 10.1.1 North America Blood Plasma Derivatives Market Overview 10.1.2 North America Blood Plasma Derivatives Market Forecasts and Analysis 10.1.3 North America Blood Plasma Derivatives Market Forecasts and Analysis - By Type 10.1.4 North America Blood Plasma Derivatives Market Forecasts and Analysis - By Application 10.1.5 North America Blood Plasma Derivatives Market Forecasts and Analysis - By End User 10.1.6 North America Blood Plasma Derivatives Market Forecasts and Analysis - By Countries 10.1.6.1 United States Blood Plasma Derivatives Market 10.1.6.1.1 United States Blood Plasma Derivatives Market by Type 10.1.6.1.2 United States Blood Plasma Derivatives Market by Application 10.1.6.1.3 United States Blood Plasma Derivatives Market by End User 10.1.6.2 Canada Blood Plasma Derivatives Market 10.1.6.2.1 Canada Blood Plasma Derivatives Market by Type 10.1.6.2.2 Canada Blood Plasma Derivatives Market by Application 10.1.6.2.3 Canada Blood Plasma Derivatives Market by End User 10.1.6.3 Mexico Blood Plasma Derivatives Market 10.1.6.3.1 Mexico Blood Plasma Derivatives Market by Type 10.1.6.3.2 Mexico Blood Plasma Derivatives Market by Application 10.1.6.3.3 Mexico Blood Plasma Derivatives Market by End User 10.2. EUROPE 10.2.1 Europe Blood Plasma Derivatives Market Overview 10.2.2 Europe Blood Plasma Derivatives Market Forecasts and Analysis 10.2.3 Europe Blood Plasma Derivatives Market Forecasts and Analysis - By Type 10.2.4 Europe Blood Plasma Derivatives Market Forecasts and Analysis - By Application 10.2.5 Europe Blood Plasma Derivatives Market Forecasts and Analysis - By End User 10.2.6 Europe Blood Plasma Derivatives Market Forecasts and Analysis - By Countries 10.2.6.1 Germany Blood Plasma Derivatives Market 10.2.6.1.1 Germany Blood Plasma Derivatives Market by Type 10.2.6.1.2 Germany Blood Plasma Derivatives Market by Application 10.2.6.1.3 Germany Blood Plasma Derivatives Market by End User 10.2.6.2 France Blood Plasma Derivatives Market 10.2.6.2.1 France Blood Plasma Derivatives Market by Type 10.2.6.2.2 France Blood Plasma Derivatives Market by Application 10.2.6.2.3 France Blood Plasma Derivatives Market by End User 10.2.6.3 Italy Blood Plasma Derivatives Market 10.2.6.3.1 Italy Blood Plasma Derivatives Market by Type 10.2.6.3.2 Italy Blood Plasma Derivatives Market by Application 10.2.6.3.3 Italy Blood Plasma Derivatives Market by End User 10.2.6.4 Spain Blood Plasma Derivatives Market 10.2.6.4.1 Spain Blood Plasma Derivatives Market by Type 10.2.6.4.2 Spain Blood Plasma Derivatives Market by Application 10.2.6.4.3 Spain Blood Plasma Derivatives Market by End User 10.2.6.5 United Kingdom Blood Plasma Derivatives Market 10.2.6.5.1 United Kingdom Blood Plasma Derivatives Market by Type 10.2.6.5.2 United Kingdom Blood Plasma Derivatives Market by Application 10.2.6.5.3 United Kingdom Blood Plasma Derivatives Market by End User 10.3. ASIA-PACIFIC 10.3.1 Asia-Pacific Blood Plasma Derivatives Market Overview 10.3.2 Asia-Pacific Blood Plasma Derivatives Market Forecasts and Analysis 10.3.3 Asia-Pacific Blood Plasma Derivatives Market Forecasts and Analysis - By Type 10.3.4 Asia-Pacific Blood Plasma Derivatives Market Forecasts and Analysis - By Application 10.3.5 Asia-Pacific Blood Plasma Derivatives Market Forecasts and Analysis - By End User 10.3.6 Asia-Pacific Blood Plasma Derivatives Market Forecasts and Analysis - By Countries 10.3.6.1 Australia Blood Plasma Derivatives Market 10.3.6.1.1 Australia Blood Plasma Derivatives Market by Type 10.3.6.1.2 Australia Blood Plasma Derivatives Market by Application 10.3.6.1.3 Australia Blood Plasma Derivatives Market by End User 10.3.6.2 China Blood Plasma Derivatives Market 10.3.6.2.1 China Blood Plasma Derivatives Market by Type 10.3.6.2.2 China Blood Plasma Derivatives Market by Application 10.3.6.2.3 China Blood Plasma Derivatives Market by End User 10.3.6.3 India Blood Plasma Derivatives Market 10.3.6.3.1 India Blood Plasma Derivatives Market by Type 10.3.6.3.2 India Blood Plasma Derivatives Market by Application 10.3.6.3.3 India Blood Plasma Derivatives Market by End User 10.3.6.4 Japan Blood Plasma Derivatives Market 10.3.6.4.1 Japan Blood Plasma Derivatives Market by Type 10.3.6.4.2 Japan Blood Plasma Derivatives Market by Application 10.3.6.4.3 Japan Blood Plasma Derivatives Market by End User 10.3.6.5 South Korea Blood Plasma Derivatives Market 10.3.6.5.1 South Korea Blood Plasma Derivatives Market by Type 10.3.6.5.2 South Korea Blood Plasma Derivatives Market by Application 10.3.6.5.3 South Korea Blood Plasma Derivatives Market by End User 10.4. MIDDLE EAST AND AFRICA 10.4.1 Middle East and Africa Blood Plasma Derivatives Market Overview 10.4.2 Middle East and Africa Blood Plasma Derivatives Market Forecasts and Analysis 10.4.3 Middle East and Africa Blood Plasma Derivatives Market Forecasts and Analysis - By Type 10.4.4 Middle East and Africa Blood Plasma Derivatives Market Forecasts and Analysis - By Application 10.4.5 Middle East and Africa Blood Plasma Derivatives Market Forecasts and Analysis - By End User 10.4.6 Middle East and Africa Blood Plasma Derivatives Market Forecasts and Analysis - By Countries 10.4.6.1 South Africa Blood Plasma Derivatives Market 10.4.6.1.1 South Africa Blood Plasma Derivatives Market by Type 10.4.6.1.2 South Africa Blood Plasma Derivatives Market by Application 10.4.6.1.3 South Africa Blood Plasma Derivatives Market by End User 10.4.6.2 Saudi Arabia Blood Plasma Derivatives Market 10.4.6.2.1 Saudi Arabia Blood Plasma Derivatives Market by Type 10.4.6.2.2 Saudi Arabia Blood Plasma Derivatives Market by Application 10.4.6.2.3 Saudi Arabia Blood Plasma Derivatives Market by End User 10.4.6.3 U.A.E Blood Plasma Derivatives Market 10.4.6.3.1 U.A.E Blood Plasma Derivatives Market by Type 10.4.6.3.2 U.A.E Blood Plasma Derivatives Market by Application 10.4.6.3.3 U.A.E Blood Plasma Derivatives Market by End User 10.5. SOUTH AND CENTRAL AMERICA 10.5.1 South and Central America Blood Plasma Derivatives Market Overview 10.5.2 South and Central America Blood Plasma Derivatives Market Forecasts and Analysis 10.5.3 South and Central America Blood Plasma Derivatives Market Forecasts and Analysis - By Type 10.5.4 South and Central America Blood Plasma Derivatives Market Forecasts and Analysis - By Application 10.5.5 South and Central America Blood Plasma Derivatives Market Forecasts and Analysis - By End User 10.5.6 South and Central America Blood Plasma Derivatives Market Forecasts and Analysis - By Countries 10.5.6.1 Brazil Blood Plasma Derivatives Market 10.5.6.1.1 Brazil Blood Plasma Derivatives Market by Type 10.5.6.1.2 Brazil Blood Plasma Derivatives Market by Application 10.5.6.1.3 Brazil Blood Plasma Derivatives Market by End User 10.5.6.2 Argentina Blood Plasma Derivatives Market 10.5.6.2.1 Argentina Blood Plasma Derivatives Market by Type 10.5.6.2.2 Argentina Blood Plasma Derivatives Market by Application 10.5.6.2.3 Argentina Blood Plasma Derivatives Market by End User 11. INDUSTRY LANDSCAPE 11.1. MERGERS AND ACQUISITIONS 11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES 11.3. NEW PRODUCT LAUNCHES 11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS 12. BLOOD PLASMA DERIVATIVES MARKET, KEY COMPANY PROFILES 12.1. GRIFOLS, S.A. 12.1.1. Key Facts 12.1.2. Business Description 12.1.3. Products and Services 12.1.4. Financial Overview 12.1.5. SWOT Analysis 12.1.6. Key Developments 12.2. SK PLASMA CO., LTD. 12.2.1. Key Facts 12.2.2. Business Description 12.2.3. Products and Services 12.2.4. Financial Overview 12.2.5. SWOT Analysis 12.2.6. Key Developments 12.3. FUSION HEALTH CARE PVT. LTD. 12.3.1. Key Facts 12.3.2. Business Description 12.3.3. Products and Services 12.3.4. Financial Overview 12.3.5. SWOT Analysis 12.3.6. Key Developments 12.4. BIOTEST AG 12.4.1. Key Facts 12.4.2. Business Description 12.4.3. Products and Services 12.4.4. Financial Overview 12.4.5. SWOT Analysis 12.4.6. Key Developments 12.5. GREEN CROSS CORPORATION 12.5.1. Key Facts 12.5.2. Business Description 12.5.3. Products and Services 12.5.4. Financial Overview 12.5.5. SWOT Analysis 12.5.6. Key Developments 12.6. BAXTER INTERNATIONAL INC. 12.6.1. Key Facts 12.6.2. Business Description 12.6.3. Products and Services 12.6.4. Financial Overview 12.6.5. SWOT Analysis 12.6.6. Key Developments 12.7. LFB S.A. 12.7.1. Key Facts 12.7.2. Business Description 12.7.3. Products and Services 12.7.4. Financial Overview 12.7.5. SWOT Analysis 12.7.6. Key Developments 12.8. OCTAPHARMA AG 12.8.1. Key Facts 12.8.2. Business Description 12.8.3. Products and Services 12.8.4. Financial Overview 12.8.5. SWOT Analysis 12.8.6. Key Developments 12.9. CSL LIMITED 12.9.1. Key Facts 12.9.2. Business Description 12.9.3. Products and Services 12.9.4. Financial Overview 12.9.5. SWOT Analysis 12.9.6. Key Developments 12.10. SHIRE PLC 12.10.1. Key Facts 12.10.2. Business Description 12.10.3. Products and Services 12.10.4. Financial Overview 12.10.5. SWOT Analysis 12.10.6. Key Developments 13. APPENDIX 13.1. ABOUT THE INSIGHT PARTNERS 13.2. GLOSSARY OF TERMS
The List of Companies
1. Grifols, S.A. 2. SK Plasma Co., Ltd. 3. Fusion Health Care Pvt. Ltd. 4. Biotest AG 5. Green Cross Corporation 6. Baxter International Inc. 7. LFB S.A. 8. Octapharma AG 9. CSL Limited 10. Shire Plc